GEN reports biomanufacturers target a fully disposable proc...( New Rochelle NY March 4 2009--The d...)
New Rochelle, NY, March 4, 2009--The disposable bioprocessing market has moved far beyond plastic bags for buffer preparation toward a range of products for cell culture and upstream and downstream operations, reports Genetic Engineering & Biotechnology News (GEN). Increasing numbers of biomanufacturing experts now believe that a completely disposable bioprocess stream is feasible and even within reach, according to the March 1 issue of GEN (www.genengnews.com/articles/chitem.aspx?aid=2818).
"It should come as no surprise that bioprocess disposables are rapidly gaining in popularity within the industry as their use minimizes expensive validation studies and avoids many costly sterilization and cleaning procedures," says John Sterling, Editor in Chief of GEN.
The largest hurdles remaining relate to disposable technology development in the areas of biosensors and chromatographic purification. Progress is being made in these areas, though, and the discussions have shifted from the challenges to an emphasis on the opportunities disposable products provide, especially in terms of ease of use, flexibility, maximizing infrastructure utilization, in addition to cost savings, environmental impact.
For example, GE Healthcare offers its ReadyMate line of genderless disposable connectors. By eliminating the need to stock both male and female connectors, inventories can be reduced by half, according to the company.
Pall's Allegro line of disposable products for small- to large-scale processing includes Kleenpak Nova capsule filters. Single-use Kleenpak Connectors, each composed of a male and a female connector, are used to link two separate presterilized fluid pathways. The company's Allegro 2-D biocontainers range in size from 50 mL to 50 L, while Allegro 3-D biocontainers and accompanying front-loading stainless steel totes are available in 100 L, 200 L, and
'/>"/>
| Contact: John Sterling jsterling@genengnews.com 914-740-2196 Mary Ann Liebert, Inc./Genetic Engineering News Source:Eurekalert |
Related biology news :
1. BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008
2. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
3. GEN reports on strategies to overcome blood-brain barrier
4. GEN reports on growing reliance on microfluidics technology
5. Cytori reports benefit of adipose-derived regenerative cells in spinal disc model
6. GEN reports growing focus on PI3-kinase pathway in cancer research
7. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
8. Orchid Cellmark Reports Third Quarter 2008 Financial Results
9. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
10. Synaptics Reports Record Results for First Quarter of Fiscal 2009
11. GEN reports on novel tools for deciphering biological networks
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |